In 2024, Lawrence Klein earned $203.29K in total compensation at Oruka Therapeutics, Inc., primarily from $203.29K salary. Most recently acquired 24,500 shares in Oct 2022. Currently holds stock worth $2.91M. 1+ years at the helm of Oruka Therapeutics, Inc..
Compensation History
Annual executive compensation data for Lawrence Klein, including salary, bonuses, and stock awards.
Year
2024
Total Compensation
$203.29K
Salary
$203.29K
Bonus
$0.00
Other
$0.00
Salary
$203.29KBoard Justification
In December 2024, our Compensation Committee adopted a compensation philosophy to frame future compensation decisions for the Company. Under this philosophy, compensation positioning is used to attract and retain key employees for the Company’s continued success and growth. While market data is helpful to the Compensation Committee in setting the compensation framework and guiding decisions, other factors such as Company strategy, stockholder feedback, tenure, performance and criticality are also considered. The compensation philosophy serves as the foundation to reinforce the Company’s business strategy and desired culture, while balancing internal and external alignment.
Bonus
$0.00Board Justification
N/A
Other Compensation
$0.00Board Justification
N/A
Restricted Stock
Board Justification
N/A
Performance Metrics
Pre-Merger Oruka established the corporate goals and targets for the 2024 bonus program, which were heavily weighted towards the preclinical development of ORKA-001 and ORKA-002, progress towards the commencement of their respective Phase 1 clinical studies and regulatory progress. In addition, the corporate goals included measures designed to ensure adequate funding for the Company.
Lawrence Klein
Founder and CEO of Oruka Therapeutics, Inc.
Education
Ph.D. in biophysics from Stanford University
CEO of Oruka Therapeutics, Inc. for
1 year 3 months (Aug 2024 - Present)
Previous Experience
Partner at Versant Venture Management, LLC; Chief Operating Officer at CRISPR Therapeutics AG
Holdings
Track Lawrence Klein's stock holdings and portfolio value over time.
Total Stock Sold
$25.30M
$25.30M
240,000 CRSP shares
What if they kept their stock?
If Lawrence Klein didn't sell their stock, today they would have:
Extra CRSP240,000 shares worth $13.69M.
This is -45.89% and $11.61M less than what they got when they sold the stock.
Insider Trading
Lawrence Klein's recent stock transactions, purchases, and sales filed with the SEC.
24,500 shares
JSPR
Oct 12, 2022
Received
$12.76M
CRSP at $127.59/share
Mar 23, 2021
Sale
$5.38M
CRSP at $215.28/share
Jan 15, 2021
Sale
$5.31M
CRSP at $75.82/share
Jun 24, 2020
Sale
$1.52M
CRSP at $60.73/share
May 11, 2020
Sale
$1.00M
CRSP at $50.02/share
Jul 10, 2019
Sale
$597.40K
CRSP at $29.87/share
Jan 2, 2019
Received
Rivals
Compare Lawrence Klein with competitor CEOs and industry peers.